Design, Synthesis, and Biological Evaluation of 1,4-Bis(2,3-dihydro-5-oxopyrrol-4-yl)-1,3-butadienes as Potential Chk1 Inhibitors
- 16 Downloads
A series of 1,4-bis(2,3-dihydro-5-oxopyrrol-4-yl)-1,3-butadienes were designed as inhibitors of checkpoint kinase 1 (Chk1), based on the structure‒activity relationships for known inhibitors through docking simulations. The docking results suggested that the title compounds were similar to known inhibitors in interaction with the catalytic site of Chk1. Twelve compounds were synthesized by a one-pot procedure from amines, dimethyl acetylenedicarboxylate, and glyoxal in water in the presence of catalytic amounts of γ-cyclodextrin. The inhibitory activities of the synthesized compounds were evaluated in vitro using EC9706 esophageal cancer cells. The results indicated that 1,4-bis(2,3-dihydro-5-oxopyrrol-4-yl)-1,3-butadienes significantly inhibited Chk1 (IC50 10.45 μM).
KeywordsChk1 inhibitors 1,4-bis(2,3-dihydro-5-oxopyrrol-4-yl)-1,3-butadienes synthesis biological testing
Unable to display preview. Download preview PDF.
- 13.Jackson, J.R., Gilmartin, A., Imburgia, C., Winkler, J.D., Marshall, L.A., and Roshak, A., Cancer Res., 2000, vol. 60, p. 566.Google Scholar
- 19.Jackson, J.-R., Gilmartin, A., and Imburgia, C., Cancer Res., 2000, vol. 60, p. 566.Google Scholar
- 20.Sun, M.M., Sun, Y.S., Zhao, Z.H., and Zhang, M.Z., Zhonghua Shiyan Waike Zazhi, 2014, vol. 31, p. 1128.Google Scholar